| August 2012, Volume 7, No. 8 |
| Curing Disease with Gene Therapy |
|
Learning Objectives
-
List the primary immune deficiencies.
-
Define chronic granulomatous disease, graft-versus-host disease, and myelodysplasia.
-
Recognize gene transfer methods in genetic therapy.
-
Understand insertional mutagenesis and somatic cell reprogramming.
-
Discuss the recombinant vector and changes in vector technology.
|
|
|
|
|
|
|
|
|
|
David A. Williams, MDCurrent source of funding from royalties: RetroNectin® produced by Takara Bio Inc. This issue does not contain a discussion of unapproved/investigative use of a commercial prod-uct/device. |
Mary C. Dinauer, MD, PhDDr. Dinauer disclosed no financial relationship relevant to this issue. This issue does not contain a discussion of unapproved/investigative use of a commercial product/device. |
Donald B. Kohn, MDDr. Kohn disclosed no financial relationship relevant to this issue. This issue does not contain a discussion of unapproved/investigative use of a commercial product/device. |
